GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 169   

Articles published

GSK 40.37 +0.90 (2.28%)
price chart
Should Gilead Sciences, Inc. Fear GlaxoSmithKline plc (ADR)?
Gilead Sciences, Inc. (NASDAQ:GILD) and GlaxoSmithKline plc (ADR) (NYSE:GSK) seem to be battling for a larger share of the HIV market.
52-Week Low Stocks To Watch : GlaxoSmithKline PLC (ADR) (NYSE:GSK), Mindray ...
The following stocks (NYSE:GSK, NYSE:MR and NYSE:JOY) are close to 52-week low. For information, the 52-week low serves as an indicator for potential investors.
British Stocks Trading on US Exchanges: GlaxoSmithKline plc (ADR) (NYSE:GSK ...
UK shares fell more than 2 percent on Tuesday, set for their worst one-day fall in over a week and with miners hit hardest after a slump in the manufacturing sector in China - the world's biggest commodity consumer - rattled global markets.
GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain
GlaxoSmithKline plc. (ADR) (NYSE:GSK) stock has gone up 7.48% since the release of its higher-than-expected second quarter fiscal '15 (2QFY15) earnings on July 29.
GlaxoSmithKline plc (ADR) (NYSE:GSK) Cautious After Legionnaire Bug Found in ...  Wall Street Observer
GlaxoSmithKline plc (ADR) (GSK) Q2 Revenues Rise, Beat Expectations
British pharmaceutical giant GlaxoSmithKline plc (ADR) (NYSE:GSK) announced second-quarter fiscal'15 earnings before the market opened today, reporting better-than-expected earnings and revenues.
Glaxo Up on Q2 Earnings Beat, Revenues Rise, View Same - Analyst Blog  Nasdaq
GlaxoSmithKline PLC delivers Q2 Group sales of �5.9 billion  DirectorsTalk Interviews
GlaxoSmithKline plc. (ADR) (GSK) Sells Two Meningitis Vaccines To Pfizer Inc ...
The need for the said transaction arose, as GSK sought to ease the concerns of regulatory authorities. The company has recently acquired Novartis's NoMenveo and Bexsero vaccines.
Here's How Pfizer Inc., GlaxoSmithKline plc Vaccines Deal Works For Both ...  Bidness ETC
GlaxoSmithKline sells meningitis drugs to Pfizer  MarketWatch
Analytic Report on GlaxoSmithKline PLC (ADR) (NYSE:GSK)
[Financial Times] GlaxoSmithKline PLC (ADR) (NYSE:GSK)(TREND ANALYSIS) Broker theorising about a �90bn takeover was greeted with a shrug by GlaxoSmithKline shareholders.
GlaxoSmithKline plc Deal Unlikely To Help Novartis AG Top Oncology Sales
Novartis AG (ADR) (NYSE:NVS) concluded its three-way asset swap transaction with GlaxoSmithKline plc. (ADR) (NYSE:GSK) in March 2015.
GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche Holding ...
New takeover rumors for GlaxoSmithKline Plc. (ADR) (NYSE:GSK) emerged Monday. Daily Mail UK reported that UK dealers were speculating Roche Holding Ltd.
GlaxoSmithKline plc (ADR) (GSK) - Bank Of America Corp Lowers 2015 Earnings ...
GlaxoSmithKline plc's (ADR) (NYSE:GSK) stock rating was reiterated as Underperform at Bank of America Merrill Lynch, with a price target set at 1,450 pence in a sell-side research report dated August 4. The stock was trading at 1,402 pence as of 9.43 ...